Bath & Body Works (NYSE:BBWI) Upgraded at BMO Capital Markets

BMO Capital Markets upgraded shares of Bath & Body Works (NYSE:BBWI) to a hold rating in a research report report published on Tuesday morning,Zacks reports.

Several other equities research analysts also recently commented on the stock. Weiss Ratings upgraded shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 9th. Barclays decreased their price target on shares of Bath & Body Works from $23.00 to $22.00 and set an “equal weight” rating for the company in a research report on Thursday, August 27th. The Goldman Sachs Group lowered shares of Bath & Body Works from a “neutral” rating to a “sell” rating and cut their price target for the stock from $23.00 to $19.00 in a report on Wednesday, July 8th. TD Cowen boosted their price objective on shares of Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Finally, Wells Fargo & Company reduced their price objective on shares of Bath & Body Works from $26.00 to $24.00 and set an “overweight” rating on the stock in a research note on Thursday, August 27th. Four analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $22.13.

Bath & Body Works Trading Down 1.5%

Bath & Body Works stock opened at $17.45 on Tuesday. The stock has a 50-day moving average price of $19.71 and a two-hundred day moving average price of $19.63. Bath & Body Works has a 12 month low of $14.27 and a 12 month high of $28.26. The company has a market capitalization of $3.52 billion, a PE ratio of 4.54, a P/E/G ratio of 1.82 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Wednesday, August 26th. The company reported $0.62 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.38. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%.The company had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.50 billion. During the same period in the previous year, the business posted $0.30 earnings per share. The business’s quarterly revenue was down 2.3% compared to the same quarter last year. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, analysts predict that Bath & Body Works will post 2.73 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 4th. Investors of record on Friday, August 21st were issued a $0.20 dividend. The ex-dividend date was Friday, August 21st. This represents a $0.80 annualized dividend and a yield of 4.6%. Bath & Body Works’s dividend payout ratio is presently 20.83%.

Institutional Trading of Bath & Body Works

A number of institutional investors have recently bought and sold shares of the company. Geneos Wealth Management Inc. grew its holdings in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the period. Danske Bank A S acquired a new position in shares of Bath & Body Works in the 3rd quarter valued at about $39,000. Global Retirement Partners LLC bought a new stake in shares of Bath & Body Works during the 4th quarter valued at about $31,000. Elevation Wealth Partners LLC boosted its position in shares of Bath & Body Works by 5,278.8% during the 2nd quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company’s stock valued at $41,000 after purchasing an additional 1,742 shares in the last quarter. Finally, Advisory Services Network LLC acquired a new stake in Bath & Body Works during the third quarter worth approximately $48,000. Institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.